valsartan,sacubitril
novartis
['valsartan', 'sacubitril,valsartan', 'sacubitril']
#esccongress | james januzzi: "in prove-hf trial at six months there was a shift in ejection fraction upwards, that continued by one year with an average rise in ejection fraction of more than 9% among individual simply just put on to sacubitril/valsartan". 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it